Cargando…

Predicting invasive breast cancer versus DCIS in different age groups

BACKGROUND: Increasing focus on potentially unnecessary diagnosis and treatment of certain breast cancers prompted our investigation of whether clinical and mammographic features predictive of invasive breast cancer versus ductal carcinoma in situ (DCIS) differ by age. METHODS: We analyzed 1,475 mal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayvaci, Mehmet US, Alagoz, Oguzhan, Chhatwal, Jagpreet, Munoz del Rio, Alejandro, Sickles, Edward A, Nassif, Houssam, Kerlikowske, Karla, Burnside, Elizabeth S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138370/ https://www.ncbi.nlm.nih.gov/pubmed/25112586 http://dx.doi.org/10.1186/1471-2407-14-584

Ejemplares similares

What Is the Optimal Threshold at Which to Recommend Breast Biopsy?
por: Burnside, Elizabeth S., et al.
Publicado: (2012)

Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions
por: Bergholtz, Helga, et al.
Publicado: (2020)

Biological Markers Predictive of Invasive Recurrence in DCIS
por: Nofech-Mozes, Sharon, et al.
Publicado: (2008)

A new perspective on breast cancer diagnostic guidelines to reduce overdiagnosis
por: Tunç, Sait, et al.
Publicado: (2022)

Is palpable DCIS more aggressive than screen-detected DCIS?
por: Balac, Nina, et al.
Publicado: (2022)

Common genetic susceptibility to DCIS and invasive ductal carcinoma
por: Sopik, Victoria, et al.
Publicado: (2016)

Identifying a Highly-Aggressive DCIS Subgroup by Studying Intra-Individual DCIS Heterogeneity among Invasive Breast Cancer Patients
por: Pape-Zambito, Dana, et al.
Publicado: (2014)

Clinicopathological characteristics and prognostic analysis of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ (DCIS) and DCIS with microinvasion (DCIS-Mi) of the breast
por: Jia, Huiqing, et al.
Publicado: (2022)

Cost-Effectiveness of Remdesivir for COVID-19 Treatment: What Are We Missing?
por: Chhatwal, Jagpreet, et al.
Publicado: (2022)

Overall survival is improved when DCIS accompanies invasive breast cancer
por: Kole, Adam J., et al.
Publicado: (2019)

Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer
por: Ward, William H., et al.
Publicado: (2019)

Ductal carcinoma in situ (DCIS)
por: Holland, R
Publicado: (2002)

Imaging features of noncalcified DCIS
por: Scudder, JM, et al.
Publicado: (2012)

Health Economics of Interventions to Tackle the Coronavirus 2019 Pandemic
por: Chhatwal, Jagpreet, et al.
Publicado: (2021)

COVID-19 Health Economics: Looking Back and Scoping the Future
por: Postma, Maarten J., et al.
Publicado: (2022)

Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
por: Magnoni, Francesca, et al.
Publicado: (2023)

Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
por: Johnson, C, et al.
Publicado: (2012)

Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
por: Clark, S E, et al.
Publicado: (2011)

Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s)
por: Scribner, Kelly C., et al.
Publicado: (2012)

FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
por: Yu, Li-Na, et al.
Publicado: (2019)

Boost und Hypofraktionierung beim DCIS
por: Dunst, Jürgen, et al.
Publicado: (2022)

Essential role of STAT5a in DCIS formation and invasion following estrogen treatment
por: Dees, Sundee, et al.
Publicado: (2020)

Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion
por: Hayward, Mary-Kate, et al.
Publicado: (2022)

The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS
por: Wallis, M G, et al.
Publicado: (2012)

Ductal carcinoma in situ (DCIS): are we overdetecting it?
por: Evans, A
Publicado: (2004)

Ductal carcinoma in situ (DCIS): are we overtreating it?
por: Dixon, JM
Publicado: (2004)

MJRA1.9 - AAI requirements of DCIs
Publicado: (Nove)

Educational Case: Ductal Carcinoma In Situ (DCIS)
por: Komforti, Miglena K., et al.
Publicado: (2019)

Low-risk DCIS. What is it? Observe or excise?
por: Pinder, Sarah E., et al.
Publicado: (2021)

Countercurrents: DCIS or Cancer? Why All the Confusion?
por: Narod, Steven A., et al.
Publicado: (2022)

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
por: Pinder, S E, et al.
Publicado: (2010)

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
por: Barnes, N, et al.
Publicado: (2006)

Is there a difference in FDG PET findings of invasive ductal carcinoma of the breast with and without coexisting DCIS?
por: Sarikaya, Ismet, et al.
Publicado: (2020)

The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancer
por: Niwińska, Anna, et al.
Publicado: (2021)

A Non-Invasive Deep Photoablation Technique to Inhibit DCIS Progression and Induce Antitumor Immunity
por: Kaneko, Kensuke, et al.
Publicado: (2022)

Alcohol-Associated Liver Disease Mortality Rates by Race Before and During the COVID-19 Pandemic in the US
por: Kulkarni, Neeti S., et al.
Publicado: (2023)

Sentinel Lymph Node Biopsy in Pure DCIS: Is It Necessary?
por: Boler, D. E., et al.
Publicado: (2012)

DCIS and axillary nodal evaluation: compliance with national guidelines
por: Mitchell, Katrina B., et al.
Publicado: (2017)

Is anti-hormonal treatment in DCIS of the breast a need?
por: Tjalma, WAA
Publicado: (2016)

Quality of DCIS information on the internet: a content analysis
por: Blackwood, Jayden, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mbc5h9gk8idkpv5mihdoq4c6c7